The MICROBIOREACTOR (i.e., MicroBrx) is our smallest and lowest-cost hollow-fiber bioreactor system designed for pursuing R&D or feasibility projects, for testing a large panel of clones or different media, or for trying out hollow-fiber technology for the first time. The MicroBrx can also be used to culture cell lines that generate low-product concentrations. 


The PRIMER bioreactor is a small-scale hollow-fiber bioreactor system designed for the research, development and optimization of processes that can later be scaled up. The Primer is ideally suited to academic labs that want to expand cell lines or generate a set amount of cell product per month. Likewise, the Primer works with larger commercial or R&D facilities that need to conduct pilot experiments and require a specific amount of cells or starting product.


The AUTOVAXID bioreactor offers a flexible, small- to medium-scale hollow-fiber bioreactor system that easily expands cell lines and produces gram amounts of biologics such as monoclonal antibodies, recombinant proteins and virus-like particles. Due to its modular setup and automated controls, the instrument can be used in many different applications, including those commonly performed at academic, biotechnology and pharmaceutical laboratories. This bioreactor requires very little technician expertise and labor in comparison with competing cell culture technologies. 


The MAXIMIZER is an automated bench-top bioreactor system that supports pilot-scale process development and the routine production of particles from adherent or suspension cell lines, including monoclonal antibodies, recombinant proteins and virus-like particles. This automated system is ideal for academic, research and pharmaceutical laboratories that are optimizing their cell culture processes and require mid- to large-scale amounts of cells or cell products equivalent to the production from a 160 L fed-batch bioreactor.


The XCELLERATOR automated hollow-fiber bioreactor system can be applied toward large-scale expansion of adherent and suspension cell lines as well as the generation of cell products including monoclonal antibodies, recombinant proteins and virus-like particles. This system is suitable for academic and research laboratories that have already validated their production protocols and now need larger batches of cells or cell-derived products. The instrument is also suitable for the large-scale production of diagnostic- and therapeutic-grade biologics.